Biopharma Daily Stock Updates - 03/24/21

$XBI $131.42 -5%

Pipeline Updates

$AKBA -5% Approval of Riona for additional indication in Japan. source

$RDUS +10% Updates for abaloparatide. source

$DVAX -6% First patient dosed in ph 2/3 covid trial. source

$PRQR +13% Ph 1/2 data from STELLAR trial of QR-421a. source

$MYOV -6% & $PFE Ph 3 data from LIBERTY study for uterine fibroids. source

$HCM -4% Initiated ph 1b/2 trial of surafitinib + tislelizumab in solid tumors. source

Financial Updates

$EVFM -10% Public offering. source

$AVEO -8% Prices offering at $8/sh. source


*Disclaimer: Information provided on and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Big Movers™ is a trademark of Amp Biotech Research, LLC

©2021 by Biopharm IQ. Website by Awaken Studio.